233 related articles for article (PubMed ID: 19883655)
1. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
Li J; Negro A; Lopez J; Bauman AL; Henson E; Dodge-Kafka K; Kapiloff MS
J Mol Cell Cardiol; 2010 Feb; 48(2):387-94. PubMed ID: 19883655
[TBL] [Abstract][Full Text] [Related]
2. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
[TBL] [Abstract][Full Text] [Related]
3. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
[TBL] [Abstract][Full Text] [Related]
4. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
5. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
6. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes.
Kapiloff MS; Piggott LA; Sadana R; Li J; Heredia LA; Henson E; Efendiev R; Dessauer CW
J Biol Chem; 2009 Aug; 284(35):23540-6. PubMed ID: 19574217
[TBL] [Abstract][Full Text] [Related]
7. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
8. The mAKAP signalosome and cardiac myocyte hypertrophy.
Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
[TBL] [Abstract][Full Text] [Related]
12. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
Golatkar V; Bhatt LK
Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
[TBL] [Abstract][Full Text] [Related]
13. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
[TBL] [Abstract][Full Text] [Related]
16. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
Pare GC; Bauman AL; McHenry M; Michel JJ; Dodge-Kafka KL; Kapiloff MS
J Cell Sci; 2005 Dec; 118(Pt 23):5637-46. PubMed ID: 16306226
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes.
Zhang L; Malik S; Kelley GG; Kapiloff MS; Smrcka AV
J Biol Chem; 2011 Jul; 286(26):23012-21. PubMed ID: 21550986
[TBL] [Abstract][Full Text] [Related]
18. mAKAP-a master scaffold for cardiac remodeling.
Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
[TBL] [Abstract][Full Text] [Related]
19. Regulation of MEF2 transcriptional activity by calcineurin/mAKAP complexes.
Li J; Vargas MA; Kapiloff MS; Dodge-Kafka KL
Exp Cell Res; 2013 Feb; 319(4):447-54. PubMed ID: 23261540
[TBL] [Abstract][Full Text] [Related]
20. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
